You are currently viewing a new version of our website. To view the old version click .
Nutrients
  • Review
  • Open Access

16 June 2019

Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern?

,
,
,
,
,
,
,
,
and
1
Department of Food, Environmental and Nutritional Sciences (DeFENS), Università degli Studi di Milano, 20133 Milan, Italy
2
Geriatria, Accettazione Geriatrica e Centro di ricerca per l’invecchiamento, IRCCS INRCA, 60127 Ancona, Italy
3
Department of Life and Environmental Sciences, Polytechnic University of Marche, Via Brecce Bianche, 60131 Ancona, Italy
4
Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UG, UK
This article belongs to the Special Issue Plant Food, Nutrition and Human Health

Abstract

Growing evidence support association between polyphenol intake and reduced risk for chronic diseases, even if there is a broad debate about the effective amount of polyphenols able to exert such protective effect. The present systematic review provides an overview of the last 10-year literature on the evaluation of polyphenol intake and its association with specific disease markers and/or endpoints. An estimation of the mean total polyphenol intake has been performed despite the large heterogeneity of data reviewed. In addition, the contribution of dietary sources was considered, suggesting tea, coffee, red wine, fruit and vegetables as the main products providing polyphenols. Total flavonoids and specific subclasses, but not total polyphenols, have been apparently associated with a low risk of diabetes, cardiovascular events and all-cause mortality. However, large variability in terms of methods for the evaluation and quantification of polyphenol intake, markers and endpoints considered, makes it still difficult to establish an evidence-based reference intake for the whole class and subclass of compounds. Nevertheless, the critical mass of data available seem to strongly suggest the protective effect of a polyphenol-rich dietary pattern even if further well targeted and methodologically sound research should be encouraged in order to define specific recommendations.

1. Introduction

The possibility to develop dietary guidelines for the intake of food bioactives with health promoting effects can be of utmost importance to try to evolve the concept of adequate nutrition to that of optimal nutrition. Clearly, this implies at least 2 levels of knowledge: (1) the availability of reliable data of food composition and food intake to estimate exposure to food bioactives and (2) the capacity to assess the amount needed to exert the protective activity.
Polyphenols have been suggested to exert a plethora of biological activities including antioxidant, anti-inflammatory, anti-microbial, anti-proliferative, pro-apoptotic activity and hormonal regulation capacity []. There is also increasing evidence that long-term intake can have favorable effects on the incidence of several cancers and other chronic diseases, including cardiovascular disease (CVD), type II diabetes, and neurodegenerative diseases []. More recently research has been focused on the impact of polyphenols on healthy aging and/or age-related diseases [].
The emerging evidence, obtained through both animal models and human studies, on the direct and indirect role of polyphenols in the modulation of metabolic and functional features of the host, has enhanced the interest for an estimation of polyphenol intake in the general population or in at risk target groups. In addition, the assessment of specificity in the protective properties of the single polyphenol classes/compounds (Figure 1) has been increased in the last years favored by the improvement of dedicated food databases (i.e., Phenol-Explorer, USDA database) reporting more accurate and detailed polyphenols composition and considering factors affecting the intake such as the “retention factors” (i.e., the loss or gain of a compound during food processing). Despite the transformation of food intake data into polyphenol intake remains still a critical, even if improved, step of the process, the accuracy of self-reported methods to evaluate dietary patterns is often limited. In particular, it has been suggested that the notion that fruit and vegetables intake represents the main dietary sources of polyphenols could be over-reported []. Finally, as far as polyphenols are concerned, the low bioavailability and extensive metabolism demonstrated in numerous studies makes it difficult to clearly state recommendations on intake.
Figure 1. Polyphenol subclasses.
Nevertheless, the analysis of polyphenol intake data registered in several target population with different dietary patterns and lifestyle/exposure may help better understanding whether it is possible to identify a range of intake apparently associated to an overall reduced risk.
To this aim a comprehensive updated review on data and tools/methods used for the estimation of polyphenol intake was performed by considering differences in total and subclasses intake depending on factors related to dietary habits. In addition, main results on the association among polyphenol intake and specific endpoints of disease risk have been taken into account, when available, to suggest possible recommendation.

1.1. Search Strategy and Study Selection

A literature search of all English language studies published was performed using PubMed (http://www.ncbi.nlm.nih.gov/pubmed), and EMBASE (http://www.embase.com/) databases (updated December 2018) with the addition of other scientific papers of relevance fount in web sources or in previously published reviews. The search terms and strategy used for the study selection were: polyphenols OR flavonoids OR anthocyanins OR flavanols OR flavanones OR flavones OR flavonols OR isoflavones OR proanthocyanidins OR phenolic acids OR hydroxycinnamic acids OR hydroxybenzoic acids OR lignans OR stilbenes AND intake. Human studies were used as further criteria of literature search. The search was limited to the last 10 years of publication. Three independent reviewers (S.B., M.M. and M.T.) conducted the literature search in the scientific databases and assessed and verified the eligibility of the studies based on the title and abstract. Disagreement between reviewers was resolved through consultation with a third reviewer (P.R. or C.D.B.) to reach a consensus. Inclusion criteria: (i) prospective, cohort and case-control studies analysing/estimating dietary total/classes/individual polyphenol intake; (ii) studies reporting association between dietary total/classes/individual polyphenol intake and endpoints of disease risk and mortality; (iii) studies published from January 2008 to December 2018. The exclusion criteria were: (i)-dietary intervention studies; (ii)-studies measuring polyphenols intake through urine excretion; (iii)-studies performed in in-vitro or in animal models; (iv)-studies reporting data on polyphenol intake from supplements (not food related); (v)-studies evaluating the association between polyphenol intake and cancer risk/mortality (numerous systematic reviews and meta-analysis have been recently performed); (vi)-published articles in a language different from English and with no accessible translation.

1.2. Data Extraction

For the papers meeting the inclusion criteria, the full text was retrieved, analysed and summarized in Tables. Data extraction was performed by three independent reviewers (S.B., M.M., M.T., P.R. and C.D.B.). The following information was collected: (i) first author name and year of publication; (ii) study design; (iii) number and subjects’ characteristics; (iv) country; (v) tools used for estimating dietary polyphenols intake; (vi) polyphenol database source; (vii) overall results. For the studies evaluating the association with disease risk or mortality this information was included in the table. Additional revisions of contents have been performed by other reviewers (N.H.L., B.K. and B.C.).

2. Results

2.1. Study Selection

The study selection process according to PRISMA guidelines is reported in Figure 2. A total of 3004 records were identified from the database search (PubMed and EMBASE) and other sources. After removing 48 duplicate articles, 2956 studies were screened and 2566 were excluded based on title and/or abstract. The full text of eligible studies (n = 390) was read; 299 studies were excluded because not meeting the inclusion criteria (n = 282) or not of interest/pertinent (n = 17). At the end of the selection process, 91 papers were included.
Figure 2. PRISMA Diagram.

2.2. Study Characteristics

The main characteristics of the 91 included studies are reported in Table 1, Table 2, Table 3 and Table 4; 45 studies focused only on polyphenol intake in specific target populations, 24 studies assessed the association between polyphenols and cardiovascular/diabetes risk (1 study included also data on CV mortality), 9 studies focused specifically on the association with mortality for cardiovascular and all other events, while 13 studies evaluated the association between polyphenol intake with others outcomes (e.g., frailty, bone fractures).
Table 1. Polyphenol intake registered in adults.
Table 2. Polyphenol intake and CVD/Diabetes risk.
Table 3. Association between polyphenol intake and all-cause/cardiovascular mortality.
Table 4. Polyphenol intake and other outcomes.

2.3. Dietary Intake of Polyphenols

Table 1 shows reported data from literature focused on polyphenols intake. A total of 45 studies were found and analyzed [,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,]. Most of the studies were performed in Europe, North America and Asia (Figure 3A). The researches (Figure 3B) were carried out in the adult + older population (63%) or only adults (20%), while few studied reported data specifically in older subjects (7%), in children and adolescents (7%); the dietary intake of polyphenols was assessed generally through 24-h dietary records (24-h DR; 56%) and food frequency questionnaire (FFQ; 31%) as reported in Figure 3C. The main scientific databases (Figure 3D) used for the estimation of polyphenol intake were USDA (22%) and Phenol-Explorer (PE; 20%). However, most of the studies combined USDA with PE and other databases and/or scientific sources (24%). Total polyphenol intake for the overall population was estimated to be about 900 mg/day; this value varied according to differences in target groups of subjects. The main food sources of polyphenols were represented by tea, coffee, red wine, fruit and vegetables.
Figure 3. Estimation of polyphenols intake among countries. Legend: (A) Target population considered; (B) Distribution of published data by country; (C) Questionnaires used to evaluate food intake; (D) Polyphenol database used for evaluation of intake. FFQ: Food Frequency Questionnaire; 24-h DR: 24-h Dietary Recall; USDA: United States Department of Agriculture; PE: Phenol-Explorer.

2.4. Polyphenol Intake and Cardiovascular Diseases/Diabetes Risk

In Table 2 the results of studies that examined the association between polyphenol intake and cardiovascular diseases risk are reported [,,,,,,,,,,,,,,,,,,,,,,,]. Seven out of 24 studies were conducted in United States (US), 2 in South America, 12 in Europe, 3 in Asia (Figure 4A). Most of the studies were carried out in the adult population—including older subjects (63%) while the remaining studies were performed in adult population (37%) i.e., aged < 65 years (Figure 4B).
Figure 4. Estimation of polyphenols intake and risk for cardiovascular diseases and diabetes. Legend: (A) Distribution of published data by country; (B) Target population considered; (C) Questionnaires used to evaluate food intake; (D) Polyphenol database used for evaluation of intake. FFQ: Food Frequency Questionnaire; 24-h DR: 24-h Dietary Recall; USDA: United States Department of Agriculture; PE: Phenol-Explorer.
Food intake was mainly assessed through FFQs (63%) or with 24-h DR (29%); 1 study adopted the FFQ in combination with other tools, while 1 study used other assessment methods (Figure 4C).
The main databases used were USDA (42%) and PE (25%). Three studied combined USDA and PE, while the rest of the studies evaluated polyphenol intake with different databases alone or in combination such as Epic Nutrient database, EuroFIR, U.K. Food Standard Agency, Flavonoid Korean Database (Figure 4D).
The association between polyphenol intake and cardiovascular disease risk and diabetes was evaluated by considering several outcomes such as: HDL-cholesterol, triacylglycerols (TAGs), TAG: HDL-cholesterol ratio, HOMA-IR (Homeostatic Model Assessment of Insuline Resistence), Body Mass Index (BMI), cardiovascular events (CV events), stroke events, hypertension and type 2 diabetes (T2D).
On the whole, 12 studies reported an inverse association between polyphenol intake and CV events. In some studies a significant decreased CV risk was observed at the highest quartile of total polyphenol intake (1170 mg/day for Spain and 2632 mg/day for Poland) [,] while no effect was demonstrated in other studies performed in Spain and Iran (1248 mg/day and 2459 mg/day respectively) [,]. Ten studies evaluated the association with polyphenol subclasses, mainly total flavonoids but only 3 found a significant inverse association with CV events [,,] with intake ranging from 115 to 944 mg/day.
As regard T2D, 1 study performed in Poland showed an increased protection for total polyphenol intake higher than 2632 mg/day while mixed results were found in the other studies focused on total flavonoids and/or subclasses only in some cases able to demonstrate significant T2D risk reduction [,,,]. Finally, 1 study [] reported an inverse association for both CV and T2D with the highest quartile of total flavonoids (585 mg/day).

2.5. Polyphenols Intake and all-Cause/Cardiovascular Mortality

In Table 3 the association between polyphenol intake and all-cause mortality is reported with a specific focus on cardiovascular mortality. A total of 10 studies [,,,,,,,,,] (Figure 5A) were found; most of the them (50%; 5 out of 10) were performed in Europe (Spain, Italy and The Netherland), 2 in USA, 2 in Australia and 1 was performed including USA, Canada and Australia. Five out of 10 trials (50%) involved older subjects (> 65 years), 3 studies were performed in adults while 2 trails included both adult and older subjects (Figure 5B). The food intake was assessed mainly by FFQ (60%; 6 out of 10 studies); however, some studies (30%) associated FFQs with other tools for the evaluation of food intake (i.e., computerized dietary history questionnaire). One study combined FFQ with EPIC questionnaire (Figure 5C). The evaluation of polyphenol intake was estimated by USDA database (30%; 3 out of 10 studies), or a combination of USDA with others database (40%), or USDA with PE (20%; 2 out of 10 studies). When polyphenol content of specific food-products was missing in available databases, data were obtained from the literature. One study estimated polyphenol intake, in particular monomeric flavan-3-ol, by considering their content in 120 commonly consumed plant foods and beverages obtained by combining results from reverse-phase HPLC and data from literature (Figure 5D).
Figure 5. Estimation of polyphenols intake, all-cause and cardiovascular mortality risk. Legend: (A) Distribution of published data by country; (B) Target population considered; (C) Questionnaires used to evaluate food intake; (D) Polyphenol database used for evaluation of intake. FFQ: Food Frequency Questionnaire; USDA: United States Department of Agriculture; PE: Phenol-Explorer.
Overall, one study that investigated the association with total polyphenol intake and all-cause mortality failed to demonstrate a significant effect []. Similar findings were also reported by considering the association between total flavonoids and CV mortality []. On the contrary, a reduction of mortality risk for cardiovascular events and all–cause mortality was associated with total flavonoid intake in the highest quintiles ranging from 360 mg/day [] to about 800 mg/day []. The impact of the single subclasses has been evaluated in some of the studies, but the effects were conflicting depending on the subject’s characteristics (i.e., age, sex) and cause of mortality. Generally, the models adjusted for the age, as confounding factor, reported a protection also for specific flavonoid subclasses such as isoflavones, flavan-3-ols, flavones. The effects in some cases were found both in women and men. However, generally adjustments for the different confounding factors (i.e., BMI, smoking and alcohol habits, energy intake, physical activity, medications, etc. affected the significance of the associations.

2.6. Polyphenols Intake and other Outcomes

Table 4 shows the associations between polyphenol intake and other outcomes in a total of 13 studies [,,,,,,,,,,,,]. The associations were evaluated for endothelial function (1 study), kidney function (1 study), bone health (i.e., bone mineral density, frailty and fractures; 3 studies), eyes health (i.e., cataract and macular degeneration; 2 studies), physical performance decline (1 study), dementia (1 study), cognitive decline (1 study) and pubertal development (1 study).
Six out of 13 studies (46%) were performed in Europe, 3 in Australia, 2 in the USA and in Asia Figure 6A). Over than a half of the studies (58%) were carried out in the older population while 33% included adult and older subjects. 1 study was performed only in adults and 1 in adolescents (Figure 6B). The most frequent tools used for the evaluation of the diet were the FFQs (77%; 10 studies), 1 study used a 24-h DR while 2 studies combined FFQs with other tools (Figure 6C). Half of the studies (50%) used USDA database, or a combination of USDA with PE (3 studies) or USDA with other databases (2 studies). Only one study performed the estimation using PE, while one study used a different specific database for the calculation of polyphenol intake (Figure 6D). An overall association between high intake of polyphenols and subclasses, and different outcomes was observed. Conversely, in the InCHIANTI study urinary total polyphenols, but not total dietary polyphenols, were associated with a lower probability of frailty or pre-frailty [] and cognitive decline []. Flavonoids have been associated with a higher endothelial function (>640 mg/day) [], a lower risk of reduced forced vital capacity and spirometric restriction of the lung (≈290 mg/day) [], a higher bone mineral density (≈490 mg/day). In addition, flavonoids have been inversely associated with bone fractures (≈1500 mg/day) [,] and macular degeneration (≈875 mg/day) []. Proanthocyanidins (≥229 mg/day) were inversely associated with risk of renal failure events and kidney insufficiency, while isoflavones (>3 mg/day) with a better pubertal development [,].
Figure 6. Estimation of polyphenols intake and other outcomes. Legend: (A) Distribution of published data by country; (B) Target population considered; (C) Questionnaires used to evaluate food intake; (D) Polyphenol database used for evaluation of intake. Legend: FFQ: Food Frequency Questionnaire; 24-h DR: 24-h Dietary Recall; USDA: United States Department of Agriculture; PE: Phenol-Explorer.

3. Discussion

The great interest for the protective role of polyphenols is demonstrated by the rapid increase of publications evaluating the mechanisms of action of these heterogeneous/complex and multi-target compounds, and also by the studies focused on association between polyphenol intake and different diseases or mortality. In particular, the association of both total or polyphenol subclasses with different types of cancer has been largely addressed in recent reviews and meta-analyses even if the effects are often nulls [,,,,,].
The present study analyzed the literature on polyphenol intake assessment per se or in relation to CVD, diabetes, other health outcomes or mortality.
As expected, the review of data obtained from different studies underlines a consistent difference in the estimated polyphenol intake which may be attributed to different methodological issues such as the type of tool administered to assess the intake, the database used for the calculation of polyphenol intake and the type of polyphenols under evaluation.
It is well known that dietary intake is difficult to measure, and single methods (i.e., questionnaires) cannot perfectly estimate dietary exposure. This is particularly critical especially for micronutrients and bioactive compounds. FFQs, and sometimes 24-h DR, represent the main tools used within the epidemiological studies to assess dietary intake. They have different characteristics; for example, FFQs consist in a pre-finite list of foods and beverages (the number of items queried typically ranges from 80 to 120) with response categories to indicate usual frequency of consumption over the time period queried. Conversely, the 24-h DR consists of an open-ended questionnaire administered by a trained interviewer able to collect detailed information about all foods and beverages consumed by the subjects in the previous 24 h. Both questionnaires present several limitations; for example, FFQs lack of detailed information about food preparation, specific food and beverages consumed, as well as different brands. Moreover, the pre-specified food list does not necessarily reflect the eating behavior of the population under study and the presence of systematic errors must be partially mitigated through appropriate statistical modeling that take into consideration the adjustments for cofounding factors such, as an example, age and energy intake. Regarding 24-h DR it requires multiple days to assess usual intake. In addition, multiple administrations are also recommended when 24-h DRs are used to examine diet impact on health outcomes or other parameters. On the other hand, it has been reported that the assessment of total flavonoid intake requires at least 6 days of weighed food records, and between 6 and 10 days to determine intake of specific flavonoid subclasses with an acceptable degree of accuracy []. Most of the studies analyzed in the present review did not perform a multiple evaluation of food intake as highly recommended thus, an under or overestimation of total polyphenols and their classes/subclasses intake cannot be excluded.
Another important critical point for the estimation of polyphenol intake is the choice of the databases. The most commonly used are USDA and Phenol-Explorer. USDA database focuses predominantly on flavonoids as aglycones (anthocyanins, flavanols, flavanones, flavones, flavonols and isoflavones), while Phenol-Explorer, in addition to the above mentioned flavonoids (mainly as glycosides), provides data also of the precursors (chalcones, dihydrochalcones and dihydroflavonols) and information on total polyphenols measured by Folin-Ciocalteu []. Despite both data sources are systematically extended to reflect most accurately phenolic contents in food, it is clear that they show several limitations. First of all, since they provide information on different classes of polyphenols, the comparison of the results obtained on the basis of the various data sources may differ. For example, some studies reported that the intake of flavonoids are generally higher when calculated using the USDA databases in relation to the Phenol-Explorer database []. In addition, despite they provide information on a wide range of foods, the list does not include all food and polyphenol sources; this represents a critical aspect since missing data have to be found by using different databases and/or by consulting the scientific literature with an increase of risk of bias. Moreover, the effect of seasonality, storage and cooking process is not always considered but certainly, it could represent a critical point. Finally, in view of these issues, it should be remarked that all databases allow only an estimation of dietary polyphenols intake. In this regard, it is noteworthy that databases do not consider non-extractable polyphenols thus contributing to an overall under estimation of intake []. This is relevant since these compounds seem to have potential protective properties exerted through gut microbiota metabolites production [].
In the present review, we found that most of the studies used USDA and Phenol-Explorer databases alone, in combination, or together with other databases and/or data sources (i.e., specific scientific publications). An estimation of polyphenol intake data obtained from reviewed studies using FFQs and from those using 24-h DR, seem to provide comparable results in terms of total polyphenol intake (FFQs 910 mg; 24-h DR 890 mg), total flavonoids (FFQs 360 mg; 24-h DR 380 mg) and total phenolic acids (FFQs 410 mg; 24-h DR 450 mg). In addition, it is noticeable that generally data come from single evaluations instead of multiple evaluations of food intake as recommendable, thus an under or overestimation of polyphenols and/or specific subclasses cannot be excluded.
Polyphenol intake is also affected by intrinsic factors such as the geographical area, the population characteristics in term of age, gender and socio-cultural factors and above all the dietary habits. In this regard, we have found that the intake of total polyphenols is higher in Japan (about 1500 mg/day) compared to European countries and North and South America (about 900 mg/day and 800 mg/day respectively). Within Europe, we found a large variability of intake between countries; Poland and France had the highest intake of total polyphenols (above 1000 mg/day), followed by Italy (about 650 mg/day) and Spain (about 300 mg/day). Conversely, within the EPIC study, Denmark showed the highest intake of total polyphenols (1786 mg/day) while Greece the lowest (584 mg/day) [].
Regarding total flavonoids, Poland and Australia had the highest intake (about 600 mg/day) while USA and South America the lowest (about 200 and 400 mg/day, respectively) followed by Asia (China and Korea, at about 60 mg/day). Finally, regarding total phenolic acids, France, Poland and Brazil had the highest intake (above 600 mg/day), while USA, Italy and Spain the lowest (about 300 mg/day). These data were also in accordance with the results obtained within EPIC study, which showed a high flavonoid and phenolic acid intake in non-Mediterranean countries [] associated to different dietary habits. For example, in the North and Central Europe, non-alcoholic beverages, in particular tea and coffee, are the main polyphenol contributors, while in South Europe the main contributors are fruits alcoholic beverages (e.g., red wine). In Asia, such as China and Korea, apples and vegetables seem to be the main polyphenol sources, while green tea in the Japanese population. Finally, tea, citrus and legumes seem to be the main polyphenol contributors in the USA.
As far as gender differences in polyphenol intake are concerned, data in literature are not univocal even if more studies suggest a higher intake in females compared to males, above all when standardization for energy intake is taken into account. In addition, differences in polyphenol sources selected seem to be dependent on gender (e.g., higher contribution of fruit and vegetables in females compared to males who are higher consumers of alcoholic beverages and coffee).
Notwithstanding, most of the data available have been assessing polyphenol intake in adults, a large number of studies considered also the intake in older subjects. Nine studies specifically reported results on total polyphenol and/or subclasses in target of older populations (2 Australia, 2 Spain, 1 Brazil, 1 Italy, 1 Poland, 1 UK and 1 Japan). Total polyphenol intake ranged from about 333 mg/day in Spain [] to 1492 mg/day in Japan []. In addition, those considering total flavonoid intake registered values from about 170 mg/day in Spain [] to about 834 mg/day in Australia []. When available the contribution of phenolic acids was approximately 30–40% of the total polyphenol intake. Studies considering different age classes found controversial results, even if generally, all studies reported differences in food habits affecting polyphenol intake. For example, Vitale et al. [] showed that flavonoid and stilbene increased with age in the TOSCA.IT study, being higher in over 65 years subjects compared to those with age lower than 65 years. Accordingly, Miranda et al. [] reported that older subjects (>60 years) from a Brazil cohort consumed more flavonoids and tyrosol than adults (20–59 years) and also more fruits. Moreover, Zamora-Ros et al. [], showed an increased intake of flavonoids, stilbenes, lignans and other polyphenols with age, while no effect on total polyphenol intake in the EPIC cohort. Other studies reported no differences in polyphenol intake depending on age, or a slight increase after energy adjustment [,]. Others (Zujko et al. []) showed lower levels of flavonoid intake in older Brazilian subjects who generally consumed less beverages and vegetables. Finally, Karam et al. [] found an increased energy adjusted polyphenol intake by age classes in older adults from Mallorca island showing also the impact of factors such as gender, educational level and lifestyle significantly affecting eating habits. Large differences in food selection depending on region/country have been underlined reflecting a different pattern of polyphenol intake.
Only 3 studies reported data on children and adolescents showing a low polyphenol intake associated to the overall dietary pattern generally poor in fruit and vegetables even if direct comparison among results is difficult due to the lack of energy adjustment of data in the different age subclasses. The main sources of polyphenols identified depending on the country were non-alcoholic beverages (UK, Argentine), fruit (apple, pear), juices, chocolate (in Helena European study []).
Extensive research on polyphenols in human studies has shown a potential role of these compounds in the modulation of CVD markers []. In the present systematic review, we found an overall inverse association between total polyphenol intake (highest quantile, above 1170 mg/day) and CV risk events and mortality. In addition, an increased protection against T2D events was observed for total polyphenol intake (mean intake of the 4th quartile) higher than 2632 mg/day []. However, the results are not univocal and 4 out of 9 papers reported no association at doses of polyphenols higher than 1200 mg/day or above (>2400 mg/day). These conflicting results could be attributed to the high heterogeneity of the studies in term of selected population characteristic, markers/endpoints measured (i.e., marker of CV risk analyzed), dietary habits (very different between countries), and polyphenol food sources (i.e., tea, coffee, fruits, alcoholic beverages).
Recent evidence from systematic reviews and meta-analyses of cross-sectional and prospective cohort studies seem to suggest that the intake of certain polyphenol classes and subclasses, more than total polyphenols, may reduce the incidence of T2D, CVD events and CVD mortality. However, most of the effects were found when comparing the highest quantiles versus the lowest. In fact, we reported a lower risk of CV events for an intake of total flavonoids ranging from 115 to 944 mg/day, an inverse association for T2D with the highest quartile of total flavonoids (585 mg/day), and a low risk of mortality for cardiovascular events and all–cause mortality for the highest quintile of total flavonoid intake (range 360–800 mg/day) [,]. These results are in line with observations reported by other authors. For example, McCullough et al. [], showed that a total flavonoid intake above 512 mg/day was inversely associated with fatal events for CVD in men and women. Feliciano and coworkers [], reported that high consumers (>788 mg/day of total flavonoids) showed an inverse association with CVD events and CVD mortality. Wang and colleagues [] found a reduced risk of CVD events for doses of flavonoids (including flavonols, anthocyanidins, proanthocyanidins, flavones, flavanones and flavan-3-ols) between 139 and 604 mg/day. Finally, Grosso et al. [] showed that increasing by 100-mg/day flavonoid intake led to a linear decreased risk of 6% and 4% of all-cause and CVD mortality.
As regard the diverse subclasses of polyphenols, several studies have reported a positive effect for flavonols, flavones, flavanones, isoflavones, anthocyanidins and proanthocyanidins. For example, Wedick and coworkers [], have shown that the highest quintile of anthocyanins (about 22.3 mg/day) and anthocyanin-rich fruit intake (≥5 times/week) was associated with a lower risk of T2D. Conversely, limited evidence is available for lignans. One study performed by Rienks and colleagues [] showed that high levels of plasma enterolactones (lignan precursors) were associated with a 30% and 45% reduction of all-cause and CVD mortality risk.
Interestingly, in the last years, a growing attention has been devoted to the impact of polyphenols on different health outcomes including for instance renal insufficiency, respiratory function, immune function, and vascular activity. For these outcomes, flavonoids and proantocyanidins have shown an apparent promising beneficial effect. Very recently, another research path has focused on the contribution of polyphenols in the older subject health outcomes. Specifically, the effect on retardation/prevention of some age-related complications such as cognitive decline, frailty and bone fractures has been investigated. On the whole, we have found an overall positive association between high intake of polyphenols and classes/subclasses, and a modulation of different outcomes associated with aging. In particular, total flavonoids and subclasses have been apparently associated with a higher bone mineral density, low risk of bone fractures and macular degeneration, while only total urinary polyphenols, but not dietary polyphenols, have been associated with a low risk of pre-frailty and frailty in older subjects. However, this type of investigation is at early stages thus, further studies have to be performed in order to strength the evidence on the associations found. In addition, since the preliminary observations on protective effects have been found mainly for specific compounds, future studies should be focused on the contribution of subclasses or individual polyphenolic compounds, and even metabolites, instead of total polyphenols.

4. Conclusions

Undoubtedly, polyphenols exert numerous biological activities as reported in a plethora of in vitro and in vivo studies. In addition, several systematic reviews and meta-analyses of observational and intervention studies have found a reduced risk for numerous chronic diseases. We documented an overall inverse association between polyphenol intake and CV risk events and mortality, as well as, between polyphenols and other outcomes of health status. However, most of the associations were found for specific polyphenol classes/subclasses as well as markers/endpoints. At present, few and conflicting results are available for total polyphenols thus, as also reported more than 10 years ago [], it is still difficult to establish a reference and/or prudent intake of total polyphenols, even if we found an approximate mean intake of about 900 mg/day. Some studies suggest an inverse association between high total flavonoid intake (generally higher 500 mg/day) and CV events and/or mortality. However, this value should be considered as a temptative level due to the elevated heterogeneity of the studies and the numerous limitations associated with the evaluation and estimation of polyphenol intake. It is then fundamental to consider that polyphenol intake correspond to differences in dietary behavior and selection of diverse food sources of the same compounds could affect the overall impact differently. Therefore, it is reasonable to argue in terms of dietary patterns more than focusing on single contributions. In this context, polyphenol-rich dietary pattern seems to exert health benefits and should be considered a valid tool for the prevention of numerous chronic diseases.
At the same time, further investigation is highly recommended in order to address the need for: (1) improved dietary assessment methods; (2) standardized and validated analytical procedures for the analysis of polyphenols and related subclasses in foods; (3) implementation of food databases increasing food items and information available on the different polyphenol subclasses; (4) validation of specific polyphenol intake biomarkers. Nevertheless, despite information from observational studies are necessary to identify potential role of diet-related compounds, the availability of well controlled and specifically targeted dietary intervention studies (addressing also dose-response effects) seems to be mandatory to allow the identification of a reference or prudent intake (e.g., in term of health-promoting properties) for food bioactives such as polyphenols, directed to the general population or specific vulnerable groups (e.g., older subjects).

Author Contributions

S.B., M.M. and M.T. performed independently the literature search through scientific databases, reviewed the abstracts, assessed and verified the eligibility of the studies. B.K., B.C. and N.H.L. acted as additional independent reviewers, fixed any bias or controversial in the study selection and contents. M.M. and S.B. prepared the tables. M.T. prepared the figures. C.D.B. revised the tables, the figures and wrote the first draft of the manuscript. M.P. and S.G. improved the manuscript. P.R., designed the study, interpreted the results, improved and critically revised the entire manuscript. A.C., R.Z.-R., C.A.-L., P.K. and A.C. participated to the critical discussion of the results and final revision of the manuscript.

Funding

This work was developed as part of the MAPLE project (Gut and blood microbiomics for studying the effect of a polyphenol-rich dietary pattern on intestinal permeability in the elderly) supported within the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI- HDHL - http://www.healthydietforhealthylife.eu/) granted by Mipaaft (Italy; D.M. 8245/7303/2016), MINECO (Spain, PCIN-2015-238), BBSRC (UK, BB/R012512/1).

Acknowledgments

We are grateful to Emanuela Mosca for her contribution to initial literature collection. C.D.B is grateful for support granted by “Piano di sostegno alla ricerca- Linea 2, azione A-grant number PSR2017-CDELB”and “PSR2018-CDELB”. P.R. and C.D.B. acknowledge the European Cooperation for Science and Technology (COST Action) CA16112 “NutRedOx: Personalized Nutrition in Aging Society: Redox Control of Major Age-related Diseases”. C.A.L. thanks 2017SGR1546 from AGAUR, CIBERFES (co-funded by the FEDER Program from EU) and ICREA Academia award 2018.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Chong, P.Y.Y.; Ho, S.C.; Kreiger, N.; Murphy, P.A.; So, E.K.F.; Chan, S.G.; Darlington, G. Isoflavonoid content of Hong Kong soy foods. J. Agric. Food Chem. 2009, 57, 5386–5390. [Google Scholar]
  2. Arts, C.; Hollman, P.C.H. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317S–325S. [Google Scholar] [CrossRef] [PubMed]
  3. Cherniack, E.P. Polyphenols and Aging. Mol. Basis Nutr. Aging Vol. Mol. Nutr. Ser. 2016, 3, 649–657. [Google Scholar]
  4. Spencer, J.P.E.; Abd El Mohsen, M.M.; Minihane, A.M.; Mathers, J.C. Biomarkers of the intake of dietary polyphenols: Strengths, limitations and application in nutrition research. Br. J. Nutr. 2008, 99, 12–22. [Google Scholar] [CrossRef] [PubMed]
  5. Song, W.O.; Chun, O.K. Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J. Nutr. 2008, 138, 1543S–1547S. [Google Scholar] [CrossRef] [PubMed]
  6. Ilow, R.; Regulska-Ilow, B.; Walkiewicz, G.; Biernat, J.; Kowalisko, A. Evaluation of bioflavonoid intake in the diets of 50-year-old inhabitants of wrocław. Adv. Clin. Exp. Med. 2008, 17, 327–336. [Google Scholar]
  7. Otaki, N.; Kimira, M.; Katsumata, S.; Uehara, M.; Watanabe, S.; Suzuki, K. Distribution and major sources of flavonoid intakes in the middle-aged Japanese women. J. Clin. Biochem. Nutr. 2009, 44, 231–238. [Google Scholar] [CrossRef] [PubMed]
  8. Chun, O.K.; Floegel, A.; Chung, S.-J.; Chung, C.E.; Song, W.O.; Koo, S.I. Estimation of antioxidant intakes from diet and supplements in U.S. adults. J. Nutr. 2009, 140, 317–324. [Google Scholar] [CrossRef] [PubMed]
  9. Yang, J.; Zhang, Y.; Chang, P.; Hao, D.; Cao, J.; Zhang, Y.; Zhao, X.; Chen, W. Reproducibility and relative validity of a food frequency questionnaire to assess intake of dietary flavonol and flavone in Chinese university campus population. Nutr. Res. 2010, 30, 520–526. [Google Scholar]
  10. Zhang, Y.; Li, Y.; Cao, C.; Cao, J.; Chen, W.; Zhang, Y.; Wang, C.; Wang, J.; Zhang, X.; Zhao, X. Dietary flavonol and flavone intakes and their major food sources in Chinese adults. Nutr. Cancer 2010, 62, 1120–1127. [Google Scholar] [CrossRef]
  11. Hanna, K.L.; O’Neill, S.; Lyons-Wall, P.M. Intake of isoflavone and lignan phytoestrogens and associated demographic and lifestyle factors in older Australian women. Asia Pac. J. Clin. Nutr. 2010, 19, 540–549. [Google Scholar] [PubMed]
  12. Pérez-Jiménez, J.; Fezeu, L.; Touvier, M.; Arnault, N.; Manach, C.; Hercberg, S.; Galan, P.; Scalbert, A. Dietary intake of 337 polyphenols in French adults 1–3. Am. J. Clin. Nutr. 2011, 93, 1220–1228. [Google Scholar] [CrossRef] [PubMed]
  13. Zamora-Ros, R.; Knaze, V.; Luján-Barroso, L.; Slimani, N.; Romieu, I.; Fedirko, V.; De Magistris, M.S.; Ericson, U.; Amiano, P.; Trichopoulou, A.; et al. Estimated dietary intakes of flavonols, flavanones and flavones in the European prospective investigation into cancer and nutrition (EPIC) 24 hour dietary recall cohort. Br. J. Nutr. 2011, 106, 1915–1925. [Google Scholar] [CrossRef] [PubMed]
  14. Wang, Y.; Chung, S.-J.; Song, W.O.; Chun, O.K. Estimation of daily proanthocyanidin intake and major food sources in the U.S. diet. J. Nutr. 2011, 141, 447–452. [Google Scholar] [CrossRef] [PubMed]
  15. Knaze, V.; Zamora-Ros, R.; Luján-Barroso, L.; Romieu, I.; Scalbert, A.; Slimani, N.; Riboli, E.; Van Rossum, C.T.M.; Bueno-De-Mesquita, H.B.; Trichopoulou, A.; et al. Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European prospective investigation into cancer and nutrition (EPIC) study. Br. J. Nutr. 2012, 108, 1095–1108. [Google Scholar] [CrossRef]
  16. Zamora-Ros, R.; Knaze, V.; Luján-Barroso, L.; Slimani, N.; Romieu, I.; Touillaud, M.; Kaaks, R.; Teucher, B.; Mattiello, A.; Grioni, S.; et al. Estimation of the intake of anthocyanidins and their food sources in the European prospective investigation into cancer and nutrition (EPIC) study. Br. J. Nutr. 2011, 106, 1090–1099. [Google Scholar] [CrossRef] [PubMed]
  17. Beking, K.; Vieira, A. An assessment of dietary flavonoid intake in the UK and Ireland. Int. J. Food Sci. Nutr. 2011, 62, 17–19. [Google Scholar] [CrossRef]
  18. Ilow, R.; Regulska-Ilow, B.; Rózańska, D.; Misiewicz, D.; Grajeta, H.; Kowalisko, A.; Biernat, J. Assessment of dietary flavonoid intake among 50-year-old inhabitants of Wroclaw in 2008. Adv. Clin. Exp. Med. 2012, 21, 353–362. [Google Scholar]
  19. Zujko, M.E.; Witkowska, A.M.; Waœkiewicz, A.; Sygnowska, E. Estimation of dietary intake and patterns of polyphenol consumption in Polish adult population. Adv. Med. Sci. 2012, 57, 375–384. [Google Scholar] [CrossRef]
  20. Lee, H.S.; Cho, Y.H.; Park, J.; Shin, H.R.; Sung, M.K. Dietary intake of phytonutrients in relation to fruit and vegetable consumption in Korea. J. Acad. Nutr. Diet. 2013, 113, 1194–1199. [Google Scholar] [CrossRef]
  21. Zamora-Ros, R.; Knaze, V.; Romieu, I.; Scalbert, A.; Slimani, N.; Clavel-Chapelon, F.; Touillaud, M. Impact of thearubigins on the estimation of total dietary flavonoids in the European prospective investigation into cancer and nutrition (EPIC) study. Eur. J. Clin. Nutr. 2019, 67, 779–782. [Google Scholar] [CrossRef] [PubMed]
  22. Tresserra-Rimbau, A.; Medina-Remón, A.; Pérez-Jiménez, J.; Martínez-González, M.A.; Covas, M.I.; Corella, D.; Salas-Salvadó, J.; Gómez-Gracia, E.; Lapetra, J.; Arós, F.; et al. Dietary intake and major food sources of polyphenols in a Spanish population at high cardiovascular risk: The PREDIMED study. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 953–959. [Google Scholar] [CrossRef] [PubMed]
  23. Vogiatzoglou, A.; Heuer, T.; Mulligan, A.A.; Lentjes, M.A.H.; Luben, R.N.; Kuhnle, G.G.C. Estimated dietary intakes and sources of flavanols in the German population (German National Nutrition Survey II). Eur. J. Nutr. 2013, 53, 635–643. [Google Scholar] [CrossRef] [PubMed]
  24. Grosso, G.; Stepaniak, U.; Topor-Madry, R.; Szafraniec, K.; Pajak, A. Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition 2014, 30, 1398–1403. [Google Scholar] [CrossRef] [PubMed]
  25. Witkowska, A.M.; Zujko, M.E.; Waśkiewicz, A.; Terlikowska, K.M.; Piotrowski, W. Comparison of various databases for estimation of dietary polyphenol intake in the population of polish adults. Nutrients 2015, 7, 9299–9308. [Google Scholar] [CrossRef] [PubMed]
  26. Kim, Y.J.; Park, M.Y.; Chang, N.; Kwon, O. Intake and major sources of dietary flavonoid in Korean adults: Korean national health and nutrition examination survey 2010–2012. Asia Pac. J. Clin. Nutr. 2015, 24, 456–463. [Google Scholar] [PubMed]
  27. Zamora-Ros, R.; Knaze, V.; Rothwell, J.A.; Hémon, B.; Moskal, A.; Overvad, K.; Tjønneland, A.; Kyrø, C.; Fagherazzi, G.; Boutron-Ruault, M.C.; et al. Dietary polyphenol intake in Europe: The European prospective investigation into cancer and nutrition (EPIC) study. Eur. J. Nutr. 2016, 55, 1359–1375. [Google Scholar] [CrossRef] [PubMed]
  28. Vogiatzoglou, A.; Mulligan, A.A.; Lentjes, M.A.H.; Luben, R.N.; Spencer, J.P.E.; Schroeter, H.; Khaw, K.T.; Kuhnle, G.G.C. Flavonoid intake in European adults (18 to 64 Years). PLoS ONE 2015, 10, e0128132. [Google Scholar] [CrossRef]
  29. Sebastian, R.S.; Enns, C.W.; Goldman, J.D.; Martin, C.L.; Steinfeldt, L.C.; Murayi, T.; Moshfegh, A.J. A new database facilitates characterization of flavonoid intake, sources, and positive associations with diet quality among US adults. J. Nutr. 2015, 145, 1239–1248. [Google Scholar] [CrossRef]
  30. Kozlowska, A.; Przekop, D.; Szostak-Wegierek, D. Flavonoids intake among Polish and Spanish students. Rocz. Panstw. Zakl. Hig. 2015, 66, 319–325. [Google Scholar]
  31. Zujko, M.E.; Witkowska, A.M.; Waskiewicz, A.; Mirończuk-Chodakowska, I. Dietary Antioxidant and Flavonoid Intakes Are Reduced in the Elderly. Oxid. Med. Cell. Longev. 2015, 2015, 843173. [Google Scholar] [CrossRef] [PubMed][Green Version]
  32. Taguchi, C.; Fukushima, Y.; Kishimoto, Y.; Suzuki-Sugihara, N.; Saita, E.; Takahashi, Y.; Kondo, K. Estimated dietary polyphenol intake and major food and beverage sources among elderly Japanese. Nutrients 2015, 7, 10269–10281. [Google Scholar] [CrossRef] [PubMed]
  33. Sun, C.; Wang, H.; Wang, D.; Chen, Y.; Zhao, Y.; Xia, W. Using an FFQ to assess intakes of dietary flavonols and flavones among female adolescents in the Suihua area of northern China. Public Health Nutr. 2015, 18, 632–639. [Google Scholar] [CrossRef] [PubMed]
  34. Kim, K.; Vance, T.M.; Chun, O.K. Estimated intake and major food sources of flavonoids among US adults: Changes between 1999–2002 and 2007–2010 in NHANES. Eur. J. Nutr. 2016, 55, 833–843. [Google Scholar] [CrossRef] [PubMed]
  35. Burkholder-Cooley, N.; Rajaram, S.; Haddad, E.; Fraser, G.E.; Jaceldo-Siegl, K. Comparison of polyphenol intakes according to distinct dietary patterns and food sources in the Adventist Health Study-2 cohort. Br. J. Nutr. 2016, 115, 2162–2169. [Google Scholar] [CrossRef]
  36. Pounis, G.; Costanzo, S.; Donati, M.B.; de Gaetano, G.; Iacoviello, L.; Bonaccio, M.; Persichillo, M.; Di Castelnuovo, A.; Krogh, V. Flavonoid and lignan intake in a Mediterranean population: Proposal for a holistic approach in polyphenol dietary analysis, the Moli-sani Study. Eur. J. Clin. Nutr. 2015, 70, 338–345. [Google Scholar] [CrossRef]
  37. Ivey, K.L.; Croft, K.; Prince, R.L.; Hodgson, J.M. Comparison of flavonoid intake assessment methods. Food Funct. 2016, 7, 3748–3759. [Google Scholar] [CrossRef]
  38. Godos, J.; Marventano, S.; Mistretta, A.; Galvano, F.; Grosso, G. Dietary sources of polyphenols in the mediterranean healthy eating, aging and lifestyle (MEAL) study cohort. Int. J. Food Sci. Nutr. 2017, 68, 750–756. [Google Scholar] [CrossRef]
  39. Miranda, A.M.; Steluti, J.; Fisberg, R.M.; Marchioni, D.M. Dietary intake and food contributors of polyphenols in adults and elderly adults of Sao Paulo: A population-based study. Br. J. Nutr. 2016, 115, 1061–1070. [Google Scholar] [CrossRef]
  40. Burkholder-Cooley, N.M.; Rajaram, S.S.; Haddad, E.H.; Oda, K.; Fraser, G.E.; Jaceldo-Siegl, K. Validating polyphenol intake estimates from a food-frequency questionnaire by using repeated 24-h dietary recalls and a unique method-of-triads approach with 2 biomarkers. Am. J. Clin. Nutr. 2017, 105, 685–694. [Google Scholar] [CrossRef]
  41. Bawaked, R.A.; Schröder, H.; Barba, L.R.; Cárdenas, G.; Rodrigo, C.P.; Peña-Quintana, L.; Fíto, M.; Majem, L.S. Dietary flavonoids of Spanish youth: Intakes, sources, and association with the Mediterranean diet. PeerJ 2017, 5, e3304. [Google Scholar] [CrossRef][Green Version]
  42. Zamora-Ros, R.; Biessy, C.; Rothwell, J.A.; Monge, A.; Lajous, M.; Scalbert, A.; López-Ridaura, R.; Romieu, I. Dietary polyphenol intake and their major food sources in the Mexican teachers’ cohort. Br. J. Nutr. 2018, 120, 353–360. [Google Scholar] [CrossRef] [PubMed]
  43. Ziauddeen, N.; Rosi, A.; Del Rio, D.; Amoutzopoulos, B.; Nicholson, S.; Page, P.; Scazzina, F.; Brighenti, F.; Ray, S.; Mena, P. Dietary intake of (poly)phenols in children and adults: Cross-sectional analysis of UK national diet and nutrition survey rolling programme (2008–2014). Eur. J. Nutr. 2018. [Google Scholar] [CrossRef] [PubMed]
  44. Karam, J.; Del Mar Bibiloni, M.; Tur, J.A. Polyphenol estimated intake and dietary sources among older adults from Mallorca Island. PLoS ONE 2018, 13, e0191573. [Google Scholar] [CrossRef] [PubMed]
  45. Rossi, M.C.; Bassett, M.N.; Sammán, N.C. Dietary nutritional profile and phenolic compounds consumption in school children of highlands of Argentine Northwest. Food Chem. 2018, 238, 111–116. [Google Scholar] [CrossRef] [PubMed]
  46. Wisnuwardani, R.W.; Marcos, A.; Kersting, M.; Sjöström, M.; Widhalm, K.; Moreno, L.A.; Forsner, M.; Michels, N.; Rothwell, J.A.; Androutsos, O.; et al. Estimated dietary intake of polyphenols in European adolescents: The HELENA study. Eur. J. Nutr. 2018. [Google Scholar] [CrossRef] [PubMed]
  47. Kent, K.; Charlton, K.E.; Lee, S.; Mond, J.; Russell, J.; Mitchell, P.; Flood, V.M. Dietary flavonoid intake in older adults: How many days of dietary assessment are required and what is the impact of seasonality? Nutr. J. 2018, 17, 7. [Google Scholar] [CrossRef]
  48. Vitale, M.; Bianchini, F.; Turco, A.A.; Barrea, A.; Riccardi, G.; Mannucci, E.; Fornengo, P.; Giorgino, F.; Romeo, F.; Santini, C.; et al. Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study. Eur. J. Nutr. 2018, 57, 679–688. [Google Scholar] [CrossRef]
  49. Nascimento-Souza, M.A.; de Paiva, P.G.; Pérez-Jiménez, J.; do Carmo Castro Franceschini, S.; Ribeiro, A.Q. Estimated dietary intake and major food sources of polyphenols in elderly of Viçosa, Brazil: A population-based study. Eur. J. Nutr. 2018, 57, 617–627. [Google Scholar] [CrossRef]
  50. Huffman, F.; Vaccaro, J.; Zarini, G.; Dixon, Z. Dietary intake of flavonoids and HDL- and LDL- cholesterol in two black ethnicities with and without type 2 diabetes. Int. J. Cardiovasc. Res. 2012, 7, 1–7. [Google Scholar]
  51. Pellegrini, N.; Valtueña, S.; Ardigò, D.; Brighenti, F.; Franzini, L.; Del Rio, D.; Scazzina, F.; Piatti, P.M.; Zavaroni, I. Intake of the plant lignans matairesinol, secoisolariciresinol, pinoresinol, and lariciresinol in relation to vascular inflammation and endothelial dysfunction in middle age-elderly men and post-menopausal women living in Northern Italy. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 64–71. [Google Scholar] [CrossRef] [PubMed]
  52. Jacques, P.F.; Cassidy, A.; Rogers, G.; Peterson, J.J.; Dwyer, J.T. Dietary flavonoid intakes and CVD incidence in the Framingham offspring cohort. Br. J. Nutr. 2015, 114, 1496–1503. [Google Scholar] [CrossRef] [PubMed]
  53. Yeon, J.Y.; Bae, Y.J.; Kim, E.Y.; Lee, E.J. Association between flavonoid intake and diabetes risk among the Koreans. Clin. Chim. Acta 2015, 439, 225–230. [Google Scholar] [CrossRef] [PubMed]
  54. Oh, J.S.; Kwon, O.; Vijayakumar, A.; Kim, H.; Kim, Y.; Chang, N. Association of dietary flavonoid intake with prevalence of type 2 diabetes mellitus and cardiovascular disease risk factors in Korean women aged ≥30 years. J. Nutr. Sci. Vitaminol. Nutr. Sci. Vitaminol. 2017, 63, 51–58. [Google Scholar] [CrossRef] [PubMed]
  55. Goetz, M.E.; Judd, S.E.; Hartman, T.J.; McClellan, W.; Anderson, A.; Vaccarino, V. Flavanone intake is inversely associated with risk of incident ischemic stroke in the reasons for geographic and racial differences in stroke (REGARDS) study. J. Nutr. 2016, 146, 2233–2243. [Google Scholar] [CrossRef] [PubMed]
  56. Goetz, M.S.M.; Hartman, T.; Vaccarino, V.; Judd, S.; McClellan, W.M. Dietary flavonoid intake and incident coronary heart disease in the reasons for geographic and racial differences in stroke study (REGARDS). Ann. Epidemiol. 2015, 25, 715. [Google Scholar] [CrossRef]
  57. Miranda, A.M.; Steluti, J.; Fisberg, R.M.; Marchioni, D.M. Association between polyphenol intake and hypertension in adults and older adults: A population-based study in Brazil. PLoS ONE 2016, 11, e0165791. [Google Scholar] [CrossRef]
  58. Cassidy, A.; Bertoia, M.; Chiuve, S.; Flint, A.; Forman, J.; Rimm, E.B. Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men. Am. J. Clin. Nutr. 2016, 104, 587–594. [Google Scholar] [CrossRef]
  59. Kim, K.; Vance, T.M.; Chun, O.K. Greater flavonoid intake is associated with improved CVD risk factors in US adults. Br. J. Nutr. 2016, 115, 1481–1488. [Google Scholar] [CrossRef]
  60. Rizzi, F.; Conti, C.; Dogliotti, E.; Terranegra, A.; Salvi, E.; Braga, D.; Ricca, F.; Lupoli, S.; Mingione, A.; Pivari, F.; et al. Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: A nutrigenetic observational study. J. Transl. Med. 2016, 14, 186. [Google Scholar] [CrossRef]
  61. Grosso, G.; Stepaniak, U.; Micek, A.; Kozela, M.; Stefler, D.; Bobak, M.; Pajak, A. Dietary polyphenol intake and risk of type 2 diabetes in the Polish arm of the health, alcohol and psychosocial factors in Eastern Europe (HAPIEE) study. Br. J. Nutr. 2017, 118, 60–68. [Google Scholar] [CrossRef] [PubMed]
  62. Cassidy, A.; Reilly, J.O.; Kay, C.; Sampson, L.; Franz, M.; Forman, J.P.; Curhan, G.; Rimm, E.B. Habitual intake of flavonoid subclasses and incident hypertension. Am. J. Clin. Nutr. 2010, 93, 338–347. [Google Scholar] [CrossRef] [PubMed]
  63. Witkowska, A.M.; Waśkiewicz, A.; Zujko, M.E.; Szcześniewska, D.; Pająk, A.; Stepaniak, U.; Drygas, W. Dietary polyphenol intake, but not the dietary total antioxidant capacity, is inversely related to cardiovascular disease in postmenopausal Polish women: Results of WOBASZ and WOBASZ II studies. Oxid. Med. Cell. Longev. 2017, 2017, 5982809. [Google Scholar] [CrossRef] [PubMed]
  64. Grosso, G.; Stepaniak, U.; Micek, A.; Stefler, D.; Bobak, M.; Pająk, A. Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur. J. Nutr. 2017, 56, 1409–1420. [Google Scholar] [CrossRef] [PubMed]
  65. Sohrab, G.; Somayeh, H.-N.; Parvin, M.; Ebrahimof, S.; Yuzbashian, E.; Fereidoun, A. Association of dietary intakes of total polyphenol and its subclasses with the risk of metabolic syndrome: Tehran lipid and glucose study. Metab. Syndr. Relat. Disord. 2018, 16, 274–281. [Google Scholar] [CrossRef] [PubMed]
  66. Mendonça, R.D.; Gea, A.; Martin-Moreno, J.M.; Martinez-Gonzalez, M.A.; Pimenta, A.M.; Carvalho, N.C.; Bes-Rastrollo, M.; Lopes, A.C.S. Total polyphenol intake, polyphenol subtypes and incidence of cardiovascular disease: The SUN cohort study. Nutr. Metab. Cardiovasc. Dis. 2018, 29, 69–78. [Google Scholar] [CrossRef]
  67. Wedick, N.M.; Pan, A.; Cassidy, A.; Rimm, E.B.; Sampson, L.; Rosner, B.; Willett, W.; Hu, F.B.; Sun, Q.; Van Dam, R.M. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am. J. Clin. Nutr. 2012, 95, 925–933. [Google Scholar] [CrossRef]
  68. Zamora-ros, R.; Forouhi, N.G.; Sharp, S.J.; Gonz, C.A.; Buijsse, B.; Guevara, M.; Schouw, Y.T.; Van Der Amiano, P.; Boeing, H.; Bredsdorff, L.; et al. Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations. J. Nutr. 2013, 144, 335–344. [Google Scholar] [CrossRef]
  69. Zamora-Ros, R.; Forouhi, N.G.; Sharp, S.J.; González, C.A.; Buijsse, B.; Guevara, M.; Van Der Schouw, Y.T.; Amiano, P.; Boeing, H.; Bredsdorff, L.; et al. The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in european populations: The EPIC-InterAct study. Diabetes Care 2013, 36, 3961–3970. [Google Scholar] [CrossRef]
  70. Jacques, P.F.; Cassidy, A.; Rogers, G.; Dwyer, J.T.; Meigs, J.B.; Peterson, J.J. Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes. J. Nutr. 2013, 143, 1474–1480. [Google Scholar] [CrossRef]
  71. Tresserra-Rimbau, A.; Medina-Remón, A.; Salas-Salvadó, J.; Estruch, R.; Lamuela-Raventós, R.M.; Rimm, E.B.; Ruiz-Gutiérrez, V.; Corella, D.; Sorlí, J.V.; Vinyoles, E.; et al. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 639–647. [Google Scholar] [CrossRef] [PubMed]
  72. Jennings, A.; Spector, T.; Cassidy, A.; Macgregor, A.; Welch, A.A. Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J. Nutr. 2013, 144, 202–208. [Google Scholar] [CrossRef] [PubMed]
  73. Ponzo, V.; Goitre, I.; Fadda, M.; Gambino, R.; de Francesco, A.; Soldati, L.; Gentile, L.; Magistroni, P.; Cassader, M.; Bo, S. Dietary flavonoid intake and cardiovascular risk: A population-based cohort study. J. Transl. Med. 2015, 13, 218. [Google Scholar] [CrossRef] [PubMed]
  74. McCullough, M.L.; Peterson, J.J.; Patel, R.; Jacques, P.F.; Shah, R.; Dwyer, J.T. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am. J. Clin. Nutr. 2012, 95, 454–464. [Google Scholar] [CrossRef] [PubMed]
  75. Zamora-ros, R.; Cherubini, A.; Urp, M.; Bandinelli, S.; Ferrucci, L.; Andres-lacueva, C. High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults. J. Nutr. 2013, 143, 1445–1450. [Google Scholar] [CrossRef] [PubMed]
  76. Zamora-Ros, R.; Jiménez, C.; Cleries, R.; Agudo, A.; Sánchez, M.J.; Sánchez-Cantalejo, E.; Molina-Montes, E.; Navarro, C.; Chirlaque, M.D.; María Huerta, J.; et al. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology 2013, 24, 726–733. [Google Scholar] [CrossRef] [PubMed]
  77. Ivey, K.L.; Lewis, J.R.; Prince, R.L.; Hodgson, J.M. Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women. Br. J. Nutr. 2013, 110, 1648–1655. [Google Scholar] [CrossRef] [PubMed]
  78. Ivey, K.L.; Hodgson, J.M.; Croft, K.D.; Lewis, J.R.; Prince, R.L. Flavonoid intake and all-cause mortality. Am. J. Clin. Nutr. 2015, 101, 1012–1020. [Google Scholar] [CrossRef] [PubMed]
  79. Dower, J.I.; Geleijnse, J.M.; Hollman, P.C.H.; Soedamah-Muthu, S.S.; Kromhout, D. Dietary epicatechin intake and 25-y risk of cardiovascular mortality: The zutphen elderly study. Am. J. Clin. Nutr. 2016, 104, 58–64. [Google Scholar] [CrossRef]
  80. Kerry, L.I.; Cassidy, A.; Eliassen, A.H.; Jensen, M.K.; Rimm, E.B.; Hodgson, J.M. Association of flavonoid-rich foods and flavonoids with risk of all-cause mortality. Br. J. Nutr. 2017, 117, 1470–1477. [Google Scholar]
  81. Zhang, F.F.; Haslam, D.E.; Terry, M.B.; Knight, J.A.; Andrulis, I.L.; Daly, M.B.; Buys, S.S.; John, E.M. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The breast cancer family registry. Cancer 2017, 123, 2070–2079. [Google Scholar] [CrossRef] [PubMed]
  82. Pounis, G.; Bonanni, A.; Galuppo, G.; Pampuch, A.; Olivieri, M.; Guszcz, T.; Sciarretta, A.; Centritto, V.; Spagnuolo, P.; Caccamo, S.; et al. Reduced mortality risk by a polyphenol-rich diet: An analysis from the Moli-sani study. Nutrition 2017, 48, 87–95. [Google Scholar] [CrossRef] [PubMed]
  83. Fisher, N.D.L.; Hurwitz, S.; Hollenberg, N.K. Habitual flavonoid intake and endothelial function in healthy humans. J. Am. Coll. Nutr. 2012, 31, 275–279. [Google Scholar] [CrossRef] [PubMed]
  84. Ivey, K.L.; Lewis, J.R.; Lim, W.H.; Lim, E.M.; Hodgson, J.M.; Prince, R.L. Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly women. PLoS ONE 2013, 8, e71166. [Google Scholar] [CrossRef] [PubMed]
  85. Lefèvre-Arbogast, S.; Samieri, C.; Dartigues, J.-F.; Féart, C.; Letenneur, L.; Delcourt, C.; Bensalem, J.; Gaudout, D.; Hejblum, B.P. Pattern of polyphenol intake and the long-term risk of dementia in older persons. Neurology 2018, 90, e1979–e1988. [Google Scholar] [CrossRef] [PubMed]
  86. Segovia-Siapco, G.; Pribis, P.; Oda, K.; Sabaté, J. Soy isoflavone consumption and age at pubarche in adolescent males. Eur. J. Nutr. 2018, 57, 2287–2294. [Google Scholar] [CrossRef] [PubMed]
  87. Rabassa, M.; Cherubini, A.; Raul, Z.-R.; Urpi-Sarda, M.; Bandinelli, S.; Ferrucci, L.; Andres-Lacueva, C. Low levels of a urinary biomarker of dietary polyphenol are associated with substantial cognitive decline over a 3-year period in older adults: The invecchiare in chianti study. J. Am. Geriatr. Soc. 2015, 63, 938–946. [Google Scholar] [CrossRef]
  88. Zhang, Z.-Q.; Su, Y.-X.; Liu, Y.-h.; He, L.-P.; Chen, Y.-M.; Liu, J. Association between dietary intake of flavonoid and bone mineral density in middle aged and elderly Chinese women and men. Osteoporos. Int. 2014, 25, 2417–2425. [Google Scholar] [CrossRef]
  89. Urpi-Sarda, M.; Andres-Lacueva, C.; Rabassa, M.; Ruggiero, C.; Zamora-Ros, R.; Bandinelli, S.; Ferrucci, L.; Cherubini, A. The relationship between urinary total polyphenols and the frailty phenotype in a community-dwelling older population: The InCHIANTI Study. J. Gerontol. Ser. Biol. Sci. Med. Sci. 2015, 70, 1141–1147. [Google Scholar] [CrossRef]
  90. Myers, G.; Prince, R.L.; Kerr, D.A.; Devine, A.; Woodman, R.J.; Lewis, J.R.; Hodgson, J.M. Tea and flavonoid intake predict osteoporotic fracture risk in elderly Australian women: A prospective study. Am. J. Clin. Nutr. 2015, 102, 958–965. [Google Scholar] [CrossRef]
  91. Ma, Y.; Gao, W.; Wu, K.; Bao, Y. Flavonoid intake and the risk of age-related cataract in China’s Heilongjiang Province. Food Nutr. Res. 2015, 59, 29564. [Google Scholar] [CrossRef] [PubMed]
  92. Rabassa, M.; Zamora-Ros, R.; Andres-Lacueva, C.; Urpi-Sarda, M.; Bandinelli, S.; Ferrucci, L.; Cherubini, A. Association between both total baseline urinary and dietary polyphenols and substantial physical performance decline risk in older adults: A 9-year follow-up of the InCHIANTI study. J. Nutr. Health Aging 2016, 20, 478–485. [Google Scholar] [CrossRef] [PubMed]
  93. Garcia-Larsen, V.; Janson, C.; Niżankowska-Mogilnicka, E.; Makowska, J.; Keil, T.; Potts, J.; Charles, D.; Brożek, G.; Matricardi, P.; van Zele, T.; et al. Dietary intake of flavonoids and ventilatory function in European adults: A GA2LEN study. Nutrients 2018, 10, 95. [Google Scholar] [CrossRef] [PubMed]
  94. Gopinath, B.; Liew, G.; Kifley, A.; Flood, V.M.; Joachim, N.; Lewis, J.R.; Hodgson, J.M.; Mitchell, P. Dietary flavonoids and the prevalence and 15-y incidence of age-related macular degeneration. Am. J. Clin. Nutr. 2018, 108, 381–387. [Google Scholar] [CrossRef] [PubMed]
  95. Pounis, G.; Costanzo, S.; de Gaetano, G.; Donati, M.B.; Bonaccio, M.; Persichillo, M.; Di Castelnuovo, A.; Iacoviello, L.; Arcari, A. Favorable association of polyphenol-rich diets with lung function: Cross-sectional findings from the Moli-sani study. Respir. Med. 2018, 136, 48–57. [Google Scholar] [CrossRef] [PubMed]
  96. Rothwell, J.A.; Knaze, V.; Zamora-Ros, R. Polyphenols: Dietary assessment and role in the prevention of cancers. Curr. Opin. Clin. Nutr. Metab. Care 2017, 20, 512–521. [Google Scholar] [CrossRef] [PubMed]
  97. Grosso, G.; Godos, J.; Lamuela-Raventos, R.; Ray, S.; Micek, A.; Pajak, A.; Sciacca, S.; D’Orazio, N.; Del Rio, D.; Galvano, F. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: Level of evidence and limitations. Mol. Nutr. Food Res. 2017, 61, 1600930. [Google Scholar] [CrossRef]
  98. Wang, Z.J.; Ohnaka, K.; Morita, M.; Toyomura, K.; Kono, S.; Ueki, T.; Tanaka, M.; Kakeji, Y.; Maehara, Y.; Okamura, T.; et al. Dietary polyphenols and colorectal cancer risk: The Fukuoka colorectal cancer study. World J. Gastroenterol. 2013, 19, 2683–2690. [Google Scholar] [CrossRef]
  99. Tse, G.; Eslick, G.D. Soy and isoflavone consumption and risk of gastrointestinal cancer: A systematic review and meta-analysis. Eur. J. Nutr. 2016, 55, 63–73. [Google Scholar] [CrossRef]
  100. Hui, C.; Qi, X.; Qianyong, Z.; Xiaoli, P.; Jundong, Z.; Mantian, M. Flavonoids, flavonoid subclasses and breast cancer risk: A meta-analysis of epidemiologic studies. PLoS ONE 2013, 8, e54318. [Google Scholar] [CrossRef]
  101. Cui, L.; Liu, X.; Tian, Y.; Xie, C.; Li, Q.; Cui, H.; Sun, C. Flavonoids, flavonoid subclasses, and esophageal cancer risk: A meta-analysis of epidemiologic studies. Nutrients 2016, 8, 350. [Google Scholar] [CrossRef] [PubMed]
  102. Ivey, K.L.; Hodgson, J.M.; Croft, K.D.; Lewis, J.R.; Prince, R.L.; Urpi-sarda, M.; Andres-Lacueva, C.; Ruggiero, C.; Zamora-Ros, R.; Bandinelli, S.; et al. Comparison of various databases for estimation of dietary polyphenol intake in the population of polish adults. Am. J. Clin. Nutr. 2015, 102, 10269–10281. [Google Scholar]
  103. Arranz, S.; Silva, J.M.; Saura-Calixto, F. Nonextractable polyphenols, usually ignored, are the major part of dietary polyphenols: A study on the Spanish diet. Mol. Nutr. Food Res. 2010, 54, 1646–1658. [Google Scholar] [CrossRef] [PubMed]
  104. González-Sarrías, A.; Espín, J.C.; Tomás-Barberán, F.A. Non-extractable polyphenols produce gut microbiota metabolites that persist in circulation and show anti-inflammatory and free radical-scavenging effects. Trends Food Sci. Technol. 2017, 69, 281–288. [Google Scholar] [CrossRef]
  105. García-Conesa, M.-T.; Kontogiorgis, C.; Andrés-Lacueva, C.; Ristic, A.K.; Pinto, P.; Combet, E.; Rai, D.; Morand, C.; Istas, G.; Gibney, E.; et al. Meta-analysis of the effects of foods and derived products containing ellagitannins and anthocyanins on cardiometabolic biomarkers: Analysis of factors influencing variability of the individual responses. Int. J. Mol. Sci. 2018, 19, pii–E694. [Google Scholar] [CrossRef] [PubMed]
  106. Feliciano, R.P.; Pritzel, S.; Heiss, C.; Rodriguez-Mateos, A. Flavonoid intake and cardiovascular disease risk. Curr. Opin. Food Sci. 2015, 2, 92–99. [Google Scholar] [CrossRef]
  107. Wang, X.; Ouyang, Y.Y.; Liu, J.; Zhao, G. Flavonoid intake and risk of CVD: A systematic review and meta-analysis of prospective cohort studies. Br. J. Nutr. 2014, 111, 1–11. [Google Scholar] [CrossRef]
  108. Grosso, G.; Micek, A.; Godos, J.; Pajak, A.; Sciacca, S.; Galvano, F.; Giovannucci, E.L. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: Systematic review and dose-response meta-analysis. Am. J. Epidemiol. 2017, 185, 1304–1316. [Google Scholar] [CrossRef]
  109. Rienks, J.; Barbaresko, J.; Nöthlings, U. Association of polyphenol biomarkers with cardiovascular disease and mortality risk: A systematic review and meta-analysis of observational studies. Nutrients 2017, 9, 415. [Google Scholar] [CrossRef]
  110. Williamson, G.; Holst, B. Dietary reference intake (DRI) value for dietary polyphenols: Are we heading in the right direction? Br. J. Nutr. 2008, 99, 55–58. [Google Scholar] [CrossRef]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.